SCTB39G

· Sinocelltech Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SCTB39G, covering 2025-07-22 to 2025-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of SCTB39G in Advanced Solid Tumours [Phase 1, Phase 2]